Marechale Capital PlcLSE: MAC

Marechale Capital Plc - Director Dealing

· MarketScreener
                
                          23 June 2026

Marechale Capital plc

("Marechale" or the "Company")

Director Dealing

Marechale Capital plc, an established London based corporate finance advisory
business, announces that on 23 June 2026 it was informed that on 23 June 2026,
Mr. Chris Kenning, Non-executive Director of the Company had transferred a part
of his shareholding, representing 9,146,670 ordinary shares in the Company, to
1Edge Insurance PCC Limited ("1Edge"), a private company indirectly controlled
by Mr. Kenning (the "Transfer").

Further, to settle a personal tax liability with respect to the Transfer, on 22
June 2026 Mr. Kenning sold 3,000,000 ordinary shares in the Company.

Mr. Kenning remains fully committed to the Company's strategic growth and
continues in his role as a Non-executive Director.

Details of the Transfer and the sale of ordinary shares are set out in the
Notification of Dealing Form below.

[]
Director/PCA    Interest    Number of  Number of      Resultant      Resultant
                prior to     ordinary   ordinary         direct         direct
                Transfer       shares     shares    interest in     percentage
                and sale  transferred       sold       ordinary      of voting
                                                  shares in the  rights in the
                                                        Company        Company
Chris         12,146,670    9,146,670  3,000,000              -              -
Kenning
1Edge[*]               -            -          -      9,146,670          3.56%

*1Edge
Insurance
PCC Limited
is 100 per
cent. owned
by Stubben
Edge Group
Limited,
whose
largest
shareholder
and
regulated
controller
is Mr.
Kenning

Following the above Transfer and sale, the aggregate interest of Mr. Kenning,
including the ordinary shares held by 1Edge, is 9,146,670 ordinary shares in the
Company, representing approximately 3.56 per cent. of the Company's enlarged
issued share capital, as noted in the announcement 22 June 2026.

Mr. Kenning also has an interest in 250,000 options over ordinary shares in the
Company.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European
Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement
via Regulatory Information Service ('RIS'), this inside information is now
considered to be in the public domain.

The Directors of the Company take responsibility for this announcement.

Enquiries

Marechale Capital                            Tel: +44 (0)20 7628 5582

Patrick Booth-Clibborn / Mark Warde-Norbury
Cairn Financial Advisers LLP                 Tel: +44 (0)20 7213 0880

(Nominated Adviser)

Jo Turner / Sandy Jamieson
Vigo Consulting                              Tel: +44 (0)20 7390 0230

(Financial Public Relations)

Jeremy Garcia / Joe Quinlan

marechale@vigoconsulting.com

Forward looking statement disclaimer

Certain statements made in this announcement are forward-looking statements.
These forward-looking statements are not historical facts but rather are based
on the Company's current expectations, estimates, and projections about its
industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,'
'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions
are intended to identify forward-looking statements. These statements are not
guarantees of future performance and are subject to known and unknown risks,
uncertainties, and other factors, some of which are beyond the Company's
control, are difficult to predict, and could cause actual results to differ
materially from those expressed or forecasted in the forward-looking statements.

The Company cautions shareholders and prospective shareholders not to place
undue reliance on these forward-looking statements, which reflect the view of
the Company only as of the date of this announcement. The forward-looking
statements made in this announcement relate only to events as of the date on
which the statements are made. The Company will not undertake any obligation to
release publicly any revisions or updates to these forward-looking statements to
reflect events, circumstances, or unanticipated events occurring after the date
of this announcement except as required by law or by any appropriate regulatory
authority.

Notification
of a
Transaction
pursuant to
Article
19(1) of
Regulation
(EU) No.
596/2014
1        Details of the person
         discharging managerial
         responsibilities/person
         closely associated
a.       Name
                                        a. Chris Kenning
                                        b. 1Edge Insurance
                                       PCC Limited
                                       ("1Edge")
2        Reason for notification
a.       Position/Status
                                        a. Non-executive
                                       Director
                                        b. PCA of Chris
                                       Kenning, Non
                                       -executive Director
b.       Initial                       Initial Notification
         notification/Amendment
3        Details of the issuer,
         emission allowance market
         participant, auction
         platform, auctioneer or
         auction monitor
a.       Name                          Marechale Capital
                                       plc
b.       LEI                           2138003NUK6SXCDIAT89
4        Details of the
         transaction(s): section to be
         repeated for (i) each type of
         instrument; (ii) each type of
         transaction; (iii) each date;
         and (iv) each place where
         transactions have been
         conducted
a.       Description of the financial  Ordinary Shares
         instrument, type of           ISIN: GB0005401087
         instrument
         Identification Code
b.       Nature of the transaction
                                        1. Transfer /
                                       receipt of ordinary
                                       shares
                                        2. Sale of ordinary
                                       shares
c.       Price(s) and volume(s):         Price(s)   Volume(s)
                                         per share
                                         (p)
Chris    Chris Kenning
Kenning
         1) 9,146,670 (Transfer of
1) N/A   shares)

2) 8.3p  2) 3,000,000

1Edge    1Edge

1) N/A   1) 9,146,670 (Receipt of
         shares)

d.       Aggregated information
           · Volume                     1. Transfer /
           · Price                     receipt of shares

           · Volume                    9,146,670
           · Price
                                       N/A

                                        2. Sale of shares

                                       3,000,000

                                       8.3p
e.       Date of the transaction
                                        1. 23/06/2026
                                        2. 22/06/2026
f.       Place of the transaction
                                        1. Outside a
                                       trading venue
                                        2. AIM


This information was brought to you by Cision http://news.cision.com

Earlier from Marechale Capital

All Marechale Capital news releases